Brazil CNS Therapeutics Market: Segmented by Drug Class (Analgesics, Nervous System Drugs, Anaesthetics, Anti-Parkinson Drugs, Multiple Sclerosis, Anti-Epileptics, Anti-Psychotic) and Distribution Channel (Hospital pharmacies, Retail pharmacies/drug stores and Online/e-Pharmacies) - Growth, Trends, and Forecasts (2019 2028)
- Published Date: 2022-12-28
- Report ID: 140027
- Pages: 200
-
Format:
Report Overview
The Brazil CNS Drugs market size stood at around USD 1.9 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Central nervous system diseases, is a group of neurological disorders that affects the structure or functioning of the brain or spinal cord, which collectively form the central nervous system (CNS). The CNS diseases include neurodegenerative diseases, neurodevelopmental diseases and traumatic injuries and drugs such as analgesics, anesthetics, nervous system drugs and others are used in the treatment for these diseases.
Market Drivers
The central nervous system drug market in Brazil is driven by increasing geriatric population, health care expenditure, investment in R&D, a better understanding of the nature of neurologic diseases and improved reimbursement policies by SUS.
Whereas the restrictions by regulatory bodies on various technologies and drugs, and lack of awareness in rural area, are the factors that are hindering the growth of the market.
1. Brazil CNS Therapeutics Market Overview..............................................
A. Market Size
2. Market Growth Drivers...
A. Increasing geriatric population
B. Increase in health care expenditure and investment
C. Improved reimbursement policies by SUS.
3. Major CNS Diseases..
A. Neurovascular diseases
B. Degenerative disease
C. Mental health trauma
D. CNS cancer
E. Others
4. Brazil CNS Therapeutics Market Segmentation.....................................
A. By Drug Class
I. Analgesics
II. Nervous system drugs
III. Anaesthetics
IV. Anti-Parkinson drugs
V. Multiple sclerosis
VI. Anti-psychotic
VII. Anti-epileptics
B. By Distribution Channel
I. Hospital pharmacies
II. Retail pharmacies/drug stores
III. Online/e-Pharmacies
5. CNS Drugs Major Products Market Share
A. Key Findings
B. Market Analysis, Insights and Forecast By Drug Type
6. Competitive Landscape...
A. Major Players
B. Products in Pipeline
7. Key Company Profiles..
A. AbbVie Inc. Company overview, Product & Services, Strategies & Financials
B. Sanofi Company overview, Product & Services, Strategies & Financials
C. AstraZeneca Plc Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape.
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth
A. New Trends and Development of CNS drug market
B. Future Opportunities
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
